ENG 105 Topic 6 DQ 2

ENG 105 Topic 6 DQ 2 What are some of the causes or consequences related to the trend you identified earlier this week? (Or, if you posted something about a policy or event, what do you see as the causes or consequences of those?) Who (or what) do you think is responsible for the problem, or who (or what) deserves credit for solving some part of the problem? During the week, review your classmates’ posts and discuss similarities and differences between your response and your peers’ responses. When used as prescribed, prescription stimulants do not pose significant health risks to individuals. Side effects of prescription stimulants are dose-dependent, and the most commonly reported side effects are decreased appetite, weight loss, headache, insomnia, abdominal pain, dizziness, nervousness, emotional lability, and dry mouth (Weyandt, et. al., 2016). The risks associated with the misuse of ADHD medications include; altered heart rate and blood pressure, insomnia, heightened anxiety, and hallucinations. Route of administration also affects the potential adverse effects. Using the drugs intravenously or intranasally significantly enhances the potential risks of prescription stimulants (Weyandt, et. al., 2016). ADHD medications are effective at one thing, helping anxious college students stay up later. Students who believed that stimulants improve school performance were 2.5 times more likely to abuse these medications, versus their peers who were unsure ADHD medication would help. The students in the unsure group were about twice as likely to misuse stimulants as those who did not believe the medications helped with grades (Norton, 2017). References Norton, A. (2017, October 16). Nearly a Third of College Kids Think ADHD Meds Boost Grades; But adolescent health experts say there's no evidence to support that belief. Consumer Health News. Retrieved from Weyandt, L. L., Oster, D. R., Marraccini, M. E., Gudmundsdottir, B. G., Munro, B. A., Rathkey, E. S., & McCallum, A. (2016). Prescription stimulant medication misuse: Where are we and where do we go from here?. Experimental and clinical psychopharmacology, 24(5), 400–414. doi:10.1037/pha